Technical Analysis for HXL - Hexima Ltd
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.013 | 0.00% | 0.000 |
HXL closed unchanged on Thursday, October 24, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 27
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 0.00% |
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is HXP124, which is in a phase IIb clinical trial for the treatment of fungal toenail infections. It operates in the topical antifungal sector of the pharmaceutical product development industry worldwide. The company was founded in 1997 and is headquartered in Melbourne, Australia.
Sector: Consumer Goods
Industry: Farm Products
Keywords: Natural Sciences Pharmaceutical Biotechnology Life Sciences Clinical Trial Health Care Pharmaceutical Industry Product Development Infection Medication Peptide Proteins Peptides Infections
Classification
Sector: Consumer Goods
Industry: Farm Products
Keywords: Natural Sciences Pharmaceutical Biotechnology Life Sciences Clinical Trial Health Care Pharmaceutical Industry Product Development Infection Medication Peptide Proteins Peptides Infections
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.175 |
52 Week Low | 0.008 |
Average Volume | 794,611 |
200-Day Moving Average | 0.017 |
50-Day Moving Average | 0.019 |
20-Day Moving Average | 0.024 |
10-Day Moving Average | 0.031 |
Average True Range | 0.015 |
RSI (14) | 47.64 |
ADX | 16.13 |
+DI | 46.316 |
-DI | 52.057 |
Chandelier Exit (Long, 3 ATRs) | 0.130 |
Chandelier Exit (Short, 3 ATRs) | 0.057 |
Upper Bollinger Bands | 0.094 |
Lower Bollinger Band | -0.045 |
Percent B (%b) | 0.42 |
BandWidth | 567.213 |
MACD Line | 0.000 |
MACD Signal Line | 0.003 |
MACD Histogram | -0.0029 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.013 | ||||
Resistance 3 (R3) | 0.013 | 0.013 | 0.013 | ||
Resistance 2 (R2) | 0.013 | 0.013 | 0.013 | 0.013 | |
Resistance 1 (R1) | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 |
Pivot Point | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 |
Support 1 (S1) | 0.013 | 0.013 | 0.013 | 0.013 | 0.013 |
Support 2 (S2) | 0.013 | 0.013 | 0.013 | 0.013 | |
Support 3 (S3) | 0.013 | 0.013 | 0.013 | ||
Support 4 (S4) | 0.013 |